Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare Reduced Intensity Conditioning protocols containing
either Thymoglobuline or Alemtuzumab in patients undergoing allogeneic transplant from
voluntary unrelated donors.